Panpra-LD
Panpra-LD Products are primarily used for
About Panpra-LD Products
Uses of Panpra-LD Products
Levosulpiride+Pantoprazole is used in the treatment of gastroesophageal reflux disease (acid reflux).
Panpra-LD Products side effects
Common
Side Effects of Panpra-LD are Vomiting, Diarrhea, Headache, Nausea, Flatulence, Dizziness, Abdominal pain, Joint pain, Drowsiness, Absence of menstrual periods, Breast enlargement in male, Unusual production of breast milk in women and men, Altered libido.
How Panpra-LD Products work
Levosulpiride + Pantoprazole is a combination of two medicines: Levosulpiride + Pantoprazole1 and Levosulpiride + Pantoprazole2. Levosulpiride + Pantoprazole1 is a prokinetic which works by increasing the release of acetylcholine (a chemical messenger). This increases the movement of stomach and intestines, and prevents reflux (acid going up to the food pipe). Levosulpiride + Pantoprazole2 is a proton pump inhibitor (PPI). It works by reducing the amount of acid in the stomach which helps in the relief of acid-related indigestion and ulcers.
Patient Concerns about Panpra-LD Products
Frequently asked questions about Panpra-LD Products
Frequently asked questions about Panpra-LD Products
Q. What is the best time to take Panpra-LD 75mg/40mg Capsule?
Take Panpra-LD 75mg/40mg Capsule exactly as directed by your doctor. It is best to take one capsule on an empty stomach daily.
Q. What are the contraindications associated with the use of Panpra-LD 75mg/40mg Capsule?
The use of Panpra-LD 75mg/40mg Capsule should be avoided in patients with known allergy to any of the components or excipients of this medicine.
Q. Can the use of Panpra-LD 75mg/40mg Capsule cause dizziness?
Yes, the use of Panpra-LD 75mg/40mg Capsule can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better.
Q. Does the use of Panpra-LD 75mg/40mg Capsule lead to increased risk of fractures?
Several studies in adults suggest that Panpra-LD 75mg/40mg Capsule may increase the risk of osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was more in patients who received high dose. High dose can mean multiple daily doses, and long-term therapy (a year or longer).
Products for Panpra-LD
MRP
₹149
Substitute brands for Panpra-LD
Penpil LS
Carezone Healthcare
1 Product
Pantonol-L
Vintek Pharmaceuticals
1 Product
Panamera L
Syndicate Life Sciences Pvt Ltd
1 Product
Pepezest-L
Giriraj Healthcare
1 Product
Panzid-L
Rezicure Pharmaceuticals
1 Product